Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.

Chartoff EH, Heusner CL, Palmiter RD.

Neuropsychopharmacology. 2005 Jul;30(7):1324-33.

PMID:
15688082
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.

Chartoff EH, Szczypka MS, Palmiter RD, Dorsa DM.

Brain Res. 2004 Oct 1;1022(1-2):71-80.

PMID:
15353215
[PubMed - indexed for MEDLINE]
4.

Phencyclidine supersensitivity in rats with neonatal dopamine loss.

Moy SS, Breese GR.

Psychopharmacology (Berl). 2002 May;161(3):255-62. Epub 2002 Apr 5.

PMID:
12021828
[PubMed - indexed for MEDLINE]
5.

Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.

Mele A, Castellano C, Felici A, Cabib S, Caccia S, Oliverio A.

Eur J Pharmacol. 1996 Jul 11;308(1):1-12.

PMID:
8836626
[PubMed - indexed for MEDLINE]
6.

Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.

Irifune M, Shimizu T, Nomoto M, Fukuda T.

Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):291-6.

PMID:
7667342
[PubMed - indexed for MEDLINE]
7.

Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids.

Griffiths MR, Cooper AJ, Barber DJ, Mitchell IJ.

Brain Res. 2000 Feb 7;855(1):1-10.

PMID:
10650124
[PubMed - indexed for MEDLINE]
9.

Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.

Yanahashi S, Hashimoto K, Hattori K, Yuasa S, Iyo M.

Brain Res. 2004 Jun 11;1011(1):84-93.

PMID:
15140647
[PubMed - indexed for MEDLINE]
10.

The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.

Leriche L, Schwartz JC, Sokoloff P.

Neuropharmacology. 2003 Aug;45(2):174-81.

PMID:
12842123
[PubMed - indexed for MEDLINE]
11.

Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.

O'Neill MF, Heron-Maxwell C, Conway MW, Monn JA, Ornstein P.

Neuropharmacology. 2003 Oct;45(5):565-74.

PMID:
12941370
[PubMed - indexed for MEDLINE]
12.

Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801.

Jacobs PS, Taylor BM, Bardgett ME.

Brain Res Dev Brain Res. 2000 Jul 30;122(1):91-5.

PMID:
10915909
[PubMed - indexed for MEDLINE]
13.

Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.

Klamer D, Zhang J, Engel JA, Svensson L.

Behav Brain Res. 2005 Apr 15;159(1):95-103.

PMID:
15795002
[PubMed - indexed for MEDLINE]
14.

Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.

Dall'Igna OP, Da Silva AL, Dietrich MO, Hoffmann A, de Oliveira RV, Souza DO, Lara DR.

Psychopharmacology (Berl). 2003 Mar;166(3):258-63. Epub 2003 Feb 13.

PMID:
12589526
[PubMed - indexed for MEDLINE]
15.

Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.

Liste I, Rodriguez-Pallares J, Caruncho HJ, Labandeira-Garcia JL.

Brain Res Mol Brain Res. 1999 Jun 18;70(1):74-83.

PMID:
10381545
[PubMed - indexed for MEDLINE]
16.
17.

N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.

Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM.

J Neurochem. 2006 Sep;98(5):1487-96.

PMID:
16923161
[PubMed - indexed for MEDLINE]
18.
19.

Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.

O'Neill MF, Hicks CA, Shaw G, Parameswaran T, Cardwell GP, O'Neill MJ.

J Pharmacol Exp Ther. 1998 Dec;287(3):839-46.

PMID:
9864262
[PubMed - indexed for MEDLINE]
Free Article
20.

Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.

Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S.

J Neurochem. 2004 Sep;90(5):1117-31.

PMID:
15312167
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk